VEGFB and breast neoplasm: Our recent study confirms this idea, where a cyclic peptidomimetic based on the helix α1 of VEGFB and a motif situated in its proximity bound to both VEGFR1 and VEGFR2 and inhibited angiogenesis and breast tumor growth [7].